ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,356.63
0.07%
Dow Jones
38,936.04
0.13%
US Dollar vs MXN
18.2429
1.99%
Brent Oil
79.435
-0.56%
Bitcoin
70,934.99
0.24%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Immunocore Holdings PLC (IMCR)

  7. Immunocore Holdings PLC (IMCR) Noticias

IMCR

Immunocore (IMCR)

Immunocore Holdings PLC
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:IMCR
FechaHoraFuenteTítuloSímboloCompañía
01/06/202407:00GlobeNewswire Inc.Immunocore presents KIMMTRAK clinical data demonstrating that patients with stable disease and confirmed tumor reduction have similar clinical outcomes to patients with partial responseNASDAQ:IMCRImmunocore Holdings PLC
31/05/202415:21Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMCRImmunocore Holdings PLC
31/05/202415:05GlobeNewswire Inc.Immunocore reports updated Phase 1 data of brenetafusp (IMC-F106C), an ImmTAC bispecific targeting PRAME, in immune checkpoint pre-treated cutaneous melanoma patients at ASCO 2024NASDAQ:IMCRImmunocore Holdings PLC
30/05/202415:00GlobeNewswire Inc.Immunocore to present at the Jefferies Global Healthcare ConferenceNASDAQ:IMCRImmunocore Holdings PLC
29/05/202406:00GlobeNewswire Inc.Immunocore converts Phase 2/3 TEBE-AM clinical trial into registrational Phase 3 trial evaluating KIMMTRAK for previously treated advanced cutaneous melanomaNASDAQ:IMCRImmunocore Holdings PLC
28/05/202415:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMCRImmunocore Holdings PLC
08/05/202406:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:IMCRImmunocore Holdings PLC
08/05/202406:00GlobeNewswire Inc.Immunocore reports first quarter financial results and provides a business updateNASDAQ:IMCRImmunocore Holdings PLC
24/04/202409:00GlobeNewswire Inc.Immunocore announces upcoming presentation and posters at ASCO 2024NASDAQ:IMCRImmunocore Holdings PLC
04/04/202415:00GlobeNewswire Inc.Immunocore to present at upcoming investor conferencesNASDAQ:IMCRImmunocore Holdings PLC
05/03/202415:30GlobeNewswire Inc.Immunocore presented two posters at CROI 2024NASDAQ:IMCRImmunocore Holdings PLC
28/02/202406:34GlobeNewswire Inc.Immunocore reports fourth quarter and full year 2023 financial results and provides a business updateNASDAQ:IMCRImmunocore Holdings PLC
28/02/202406:33Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:IMCRImmunocore Holdings PLC
26/02/202417:46Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IMCRImmunocore Holdings PLC
22/02/202406:00GlobeNewswire Inc.Immunocore announces clinical trial collaboration and supply agreement with Bristol Myers Squibb to evaluate IMC-F106C (PRAME HLA-A02) in combination with nivolumab in its registrational Phase 3 first-line advanced cutaneous melanoma trialNASDAQ:IMCRImmunocore Holdings PLC
21/02/202406:00GlobeNewswire Inc.Immunocore to report fourth quarter and full year 2023 financial results and host call on February 28, 2024NASDAQ:IMCRImmunocore Holdings PLC
30/01/202422:30GlobeNewswire Inc.Immunocore Prices Upsized Convertible Senior Notes OfferingNASDAQ:IMCRImmunocore Holdings PLC
29/01/202415:05GlobeNewswire Inc.Immunocore Announces Proposed Convertible Senior Notes OfferingNASDAQ:IMCRImmunocore Holdings PLC
05/01/202406:00GlobeNewswire Inc.Immunocore announces strategic priorities and pipeline expansion ahead of 42nd Annual J.P. Morgan Healthcare Conference presentationNASDAQ:IMCRImmunocore Holdings PLC
03/01/202406:00GlobeNewswire Inc.Immunocore to present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:IMCRImmunocore Holdings PLC
02/01/202415:57Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:IMCRImmunocore Holdings PLC
30/11/202303:00GlobeNewswire Inc.Levicept Appoints Eliot Forster as CEONASDAQ:IMCRImmunocore Holdings PLC
07/11/202306:09Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMCRImmunocore Holdings PLC
07/11/202306:00GlobeNewswire Inc.Immunocore Reports Third Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:IMCRImmunocore Holdings PLC
01/11/202315:01GlobeNewswire Inc.Immunocore announces upcoming poster presentations at SITC Annual Meeting 2023 and SMR Congress 2023NASDAQ:IMCRImmunocore Holdings PLC
21/10/202307:45GlobeNewswire Inc.Immunocore presents three-year overall survival data from the KIMMTRAK Phase 3 trialNASDAQ:IMCRImmunocore Holdings PLC
06/10/202306:01GlobeNewswire Inc.Immunocore announces upcoming presentation and posters at ESMO 2023NASDAQ:IMCRImmunocore Holdings PLC
10/08/202306:00GlobeNewswire Inc.Immunocore Reports Second Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:IMCRImmunocore Holdings PLC
03/08/202307:00GlobeNewswire Inc.Immunocore to report second quarter 2023 financial results and host call on August 10, 2023NASDAQ:IMCRImmunocore Holdings PLC
15/06/202316:18Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:IMCRImmunocore Holdings PLC
 Showing the most relevant articles for your search:NASDAQ:IMCR

Su Consulta Reciente

FX
EURUSD
Euro vs US Dollar
NYSE
NKE
Nike
FX
EURMXN
Euro vs MXN
CCOM
US500
US 500
NYSE
VZ
Verizon Communications
NYSE
BAC
Bank of America
NASDAQ
AAPL
Apple
NYSE
DIS
Walt Disney
NYSE
MRK
Merck
CCOM
US30
US 30
AMEX
XLF
Financial Select Sector
NYSE
CVX
Chevron
USOTC
RHHBY
Roche (QX)
COIN
SOLUSD
Solana
AMEX
SPY
SPDR S&P 500
USOTC
DTEGY
Deutsche Telekom (QX)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados